about
Genome-wide and fine-resolution association analysis of malaria in West AfricaEfficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of agePlasmodium falciparum gametocyte carriage in asymptomatic children in western KenyaMalaria morbidity and immunity among residents of villages with different Plasmodium falciparum transmission intensity in North-Eastern TanzaniaKnowledge of malaria influences the use of insecticide treated nets but not intermittent presumptive treatment by pregnant women in TanzaniaMalaria diagnosis and treatment: one size does not fit allThe contribution of microscopy to targeting antimalarial treatment in a low transmission area of TanzaniaRapid screening for glucose-6-phosphate dehydrogenase deficiency and haemoglobin polymorphisms in Africa by a simple high-throughput SSOP-ELISA methodVertical stratification of adult mosquitoes (Diptera: Culicidae) within a tropical rainforest in Sabah, MalaysiaThe relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assaysCurrent Mathematical Models for Analyzing Anti-Malarial Antibody Data with an Eye to Malaria Elimination and EradicationA systematic review of sub-microscopic Plasmodium vivax infectionRationale for short course primaquine in Africa to interrupt malaria transmissionA phase 3 trial of RTS,S/AS01 malaria vaccine in African infantsEffectiveness of a serological tool to predict malaria transmission intensity in an elimination settingPrimaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunateModelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensityReducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategiesRandomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in TanzaniaPromiscuous expression of α-tubulin II in maturing male and female Plasmodium falciparum gametocytesThe potential contribution of mass treatment to the control of Plasmodium falciparum malariaMosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriersSerology for trachoma surveillance after cessation of mass drug administrationThe Impact of Hotspot-Targeted Interventions on Malaria Transmission in Rachuonyo South District in the Western Kenyan Highlands: A Cluster-Randomized Controlled TrialSurveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serologySerological evidence of discrete spatial clusters of Plasmodium falciparum parasitesSerological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial GuineaSafety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian ChildrenThe dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in TanzaniaPregnant Women: An Overlooked Asset to Plasmodium falciparum Malaria Elimination Campaigns?Freedom from Infection: Confirming Interruption of Malaria Transmission.Impact of metric and sample size on determining malaria hotspot boundariesImmunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trialMolecular Characterization Reveals Diverse and Unknown Malaria Vectors in the Western Kenyan HighlandsEstimating malaria transmission intensity from Plasmodium falciparum serological data using antibody density models.Examination of Antibody Responses as a Measure of Exposure to Malaria in the Indigenous Batwa and Their Non-Indigenous Neighbors in Southwestern Uganda.Quantifying behavioural interactions between humans and mosquitoes: evaluating the protective efficacy of insecticidal nets against malaria transmission in rural Tanzania.Loss of population levels of immunity to malaria as a result of exposure-reducing interventions: consequences for interpretation of disease trends.Low density parasitaemia, red blood cell polymorphisms and Plasmodium falciparum specific immune responses in a low endemic area in northern TanzaniaRapid assessment of malaria transmission using age-specific sero-conversion rates.
P50
Q24632119-D99C9D9D-C300-499C-AAFF-BE4CC33FAE92Q24658073-961C541C-A391-4BF5-AF34-2551A578E59AQ24798247-154E458A-5BC1-45FC-A342-60B5B71927F3Q24800714-73CD68A7-7546-4ED7-9884-38F9777934D3Q24801346-C08BC9A8-5E11-4F04-AD13-18BC93DAB8C2Q24813758-D43F94FB-1555-42B3-B3A3-E8D1B5822879Q25255578-E97B05E9-4DE6-4E1A-9982-9BAB7D49230CQ25256808-05038C0C-2066-4AD1-9427-6F1A709F2427Q26315255-A9884EFE-9C21-4394-8097-CBCB8E43F911Q26315349-1BDCBED7-30D5-4BF7-9170-3FA39DF8ADFCQ26771746-1946D7AE-0C7B-49F5-BF2E-6FC4D9D25B53Q26782683-C916024D-E58F-4AC4-B5A0-888BBC12954FQ27006552-332E3B2C-021F-4C3E-B4AA-033CD5B72ADBQ28278852-FF46307D-1993-41C9-8AED-89CA907B92B3Q28365339-86CC4ADA-C96C-4AEA-9AF1-C912C6DB70B2Q28469316-2F0CB305-1BE1-4BAD-8DC8-7174F288465AQ28474141-C7E29F04-895B-479F-870E-EB64DB2A1EFBQ28475084-BEEB3A59-EDA6-4072-B9FA-068786429EA7Q28475232-66266BAA-0B01-44D8-9C9F-B4235CF03633Q28476657-71F30162-8FCF-4177-8984-3D5D9545F2A3Q28478260-5EA9D823-4CAF-4C15-8A29-CB8D42C473B1Q28482471-672D90DC-D387-4134-A229-5FA1093C2FD0Q28543658-5E952B31-7D34-4E19-9D1B-15CA37A374C3Q28551321-A8AD16AD-C2E1-4248-9353-3F0449ED57C3Q28740283-261494E4-39C1-4B95-ACA2-EC30B5A5677AQ28743081-20843E09-4680-4AB3-A32A-6CE00EB77B41Q28744515-09874359-F826-43AC-842B-ACE68F72A6CFQ28744573-EEFCD736-9790-4C7E-9993-8DE286B16CDDQ28744581-F9E42AE6-45D1-448C-A8BF-430802E9E458Q30235017-BE3E4489-9646-4B0B-8DB4-272BF261FFDBQ30238905-E872C21B-8372-495E-AFAA-C31D51781E38Q30844998-C44CD5F3-4ABE-4EEA-B2BF-C04F28538B65Q30991737-029B511B-ABAC-49B3-96CA-6D6387DE3440Q31038254-3EEA1BB1-CD39-4CED-A8AD-DA94C994B9BDQ31043964-90C2EE70-3EF0-484D-8E69-ED90B8515DB2Q31145194-08E024A1-C1F6-44CE-842A-89BA2077BFD3Q33263270-4FF9999F-E014-48A1-9DCA-6E6A1AD6B431Q33406496-98287FB1-DF31-4954-AEED-627E9276F539Q33449934-664418FE-DDF7-48BB-83C7-735228327C04Q33475618-05FE8D8E-3AB7-4B3D-BD75-AC4853856208
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chris J Drakeley
@ast
Chris J Drakeley
@en
Chris J Drakeley
@es
Chris J Drakeley
@nl
type
label
Chris J Drakeley
@ast
Chris J Drakeley
@en
Chris J Drakeley
@es
Chris J Drakeley
@nl
prefLabel
Chris J Drakeley
@ast
Chris J Drakeley
@en
Chris J Drakeley
@es
Chris J Drakeley
@nl
P106
P21
P31
P496
0000-0003-4863-075X